*[image: A screenshot of a cell phone Description automatically generated]* *Monoclonal Antibodies from Bench to Bedside: Development in an Academic Laboratory Core. Challenges* *Monday, August 24, 2020 11:00 a.m.–12:00 p.m. ET **Add to Calendar <https://us02web.zoom.us/meeting/tZYoduihqDwqHd3R3FpdHkIUCBBxdSejoq2R/ics>* *Register Here <https://us02web.zoom.us/j/82511967079?pwd=SUo5WG1rWG9aNGd4ZHUrQWQ0WDhTdz09>*
This presentation will address different approaches that successfully develop an anti-immune checkpoint antibody and other antibodies licensed to Pharma companies and in ongoing clinical trials. Other approaches under development will also be addressed. Register today to join us for this timely and informative presentation. Speakers: *David Blum, Ph.D.* Director, Bioexpression and Fermentation Facility Director, Master of Biomanufacturing and Bioprocessing University of Georgia *Laura Bover, PhD* Professor Depts. of Genomic Medicine/Immunology Director, Monoclonal Antibodies Core Facility MD Anderson Cancer Center University of Texas